Lab
Laboratorio Sagrada Familia Corp.
Laboratorio Sagrada Familia Corp. was paid $2.99M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 16% of everything it billed.
33Billing provider infoLABORATORIO SAGRADA FAMILIA CORP.
VILLALBA, PR 00766
VILLALBA, PR 00766
33aNPI1265523583assigned 09/28/2006
33bProvider typeClinical Medical Laboratory
28Total paid$2.99M
24GClaims239,092
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#25 of 777
Median peer was paid$278K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,067 | $242K | |
| 2019 | 26,959 | $201K | |
| 2020 | 23,863 | $328K | |
| 2021 | 37,609 | $664K | |
| 2022 | 37,483 | $589K | |
| 2023 | 48,310 | $569K | |
| 2024incomplete | 32,801 | $398K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16% | 13,590 | 11,875 | $467K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 13% | 16,538 | 13,969 | $399K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.0% | 5,360 | 4,762 | $268K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.6% | 14,872 | 13,941 | $227K |
| 80061 | Lipid panel | 5.8% | 14,375 | 13,217 | $175K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.1% | 10,994 | 5,280 | $152K |
| 80053 | Comprehensive metabolic panel | 4.8% | 15,151 | 13,699 | $144K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.6% | 16,099 | 13,527 | $109K |
| 36415 | Collection of venous blood by venipuncture | 3.0% | 12,662 | 11,077 | $90K |
| 85027 | 2.5% | 13,446 | 12,607 | $75K | |
| 86738 | 2.3% | 5,866 | 5,259 | $70K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.3% | 2,632 | 2,375 | $68K |
69 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.3% | 2,222 | $67K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.2% | 2,242 | $65K |
| 86328 | 1.7% | 2,816 | $52K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.7% | 5,869 | $50K |
| 81000 | 1.4% | 13,529 | $43K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 5,669 | $42K |
| 82274 | 1.2% | 2,677 | $36K | |
| 86701 | 1.2% | 4,418 | $35K | |
| 84153 | 1.2% | 2,185 | $35K | |
| 85007 | 1.1% | 11,279 | $33K | |
| 87088 | <1% | 3,682 | $27K | |
| 86702 | <1% | 2,126 | $24K | |
| 84439 | <1% | 2,887 | $23K | |
| 82607 | <1% | 1,711 | $22K | |
| 86803 | <1% | 1,402 | $18K | |
| 81001 | <1% | 6,917 | $18K | |
| 82043 | <1% | 3,417 | $17K | |
| 86592 | <1% | 4,226 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,997 | $14K |
| 85730 | <1% | 1,781 | $9K | |
| 87276 | <1% | 657 | $7K | |
| 87275 | <1% | 657 | $7K | |
| 85610 | <1% | 1,826 | $6K | |
| 85651 | <1% | 1,943 | $6K | |
| 84703 | <1% | 740 | $5K | |
| 86769 | <1% | 178 | $5K | |
| 87590 | <1% | 236 | $4K | |
| 82570 | <1% | 960 | $4K | |
| 87490 | <1% | 243 | $4K | |
| 87071 | <1% | 500 | $4K | |
| 80074 | <1% | 100 | $4K | |
| 84550 | <1% | 988 | $4K | |
| 82947 | <1% | 973 | $3K | |
| 83655 | <1% | 268 | $3K | |
| 87077 | <1% | 386 | $3K | |
| 87186 | <1% | 343 | $3K | |
| 87081 | <1% | 419 | $2K | |
| 86038 | <1% | 212 | $2K | |
| 84146 | <1% | 126 | $2K | |
| 84460 | <1% | 433 | $2K | |
| 84450 | <1% | 433 | $2K | |
| 83970 | <1% | 39 | $2K | |
| 86140 | <1% | 274 | $1K | |
| 83001 | <1% | 70 | $1K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 85 | $872.09 |
| 86304 | <1% | 39 | $710.62 | |
| 86706 | <1% | 73 | $686.37 | |
| 83002 | <1% | 39 | $663.23 | |
| 84436 | <1% | 104 | $641.15 | |
| 80050 | General health panel | <1% | 43 | $589.53 |
| 86708 | <1% | 55 | $578.00 | |
| 86704 | <1% | 53 | $551.98 | |
| 86707 | <1% | 54 | $539.37 | |
| 82950 | <1% | 112 | $474.95 | |
| 84702 | <1% | 32 | $424.42 | |
| 80076 | <1% | 56 | $398.89 | |
| 84100 | <1% | 111 | $365.03 | |
| 82465 | <1% | 75 | $293.78 | |
| 86431 | <1% | 69 | $286.82 | |
| 82565 | <1% | 64 | $281.56 | |
| 84478 | <1% | 53 | $277.96 | |
| 87899 | <1% | 139 | $265.06 | |
| 84479 | <1% | 44 | $257.19 | |
| 87177 | <1% | 30 | $230.75 | |
| 84520 | <1% | 61 | $204.19 | |
| 86677 | <1% | 13 | $172.90 | |
| 82951 | <1% | 13 | $157.48 | |
| 83540 | <1% | 20 | $111.80 | |
| 84156 | <1% | 14 | $43.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCINTRON, TENSY (MEDICAL TECHNOLOGIST OWNER)
| Provider | Location | Paid |
|---|---|---|
| Cdva Corp | Villalba, PR | $1.49M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.